Lymphocytes from diabetics suppress insulin release in vitro

Diabetologia. 1981 Jul;21(1):41-6. doi: 10.1007/BF03216222.


The insulin response of isolated islet cells to glucose and theophylline in vitro was studied after incubation with lymphocytes. The test was employed to explore cell-mediated immunity in diabetics. A significant inhibition of insulin response to glucose and theophylline as compared to insulin release in a "basal" medium was found after incubation with blood lymphocytes from 21 out of 23 insulin-dependent diabetics (mean secretion index 18 +/- 18 versus 118 + 8 (SEM) % in control subjects). Most of the patients studied had associated autoimmune diseases: all of these displayed inhibition of insulin release. In six cases, the diabetes had a recent onset with no associated autoimmune disease: four of them displayed the same inhibition. No inhibition was found in the 26 control subjects and in seven non-insulin-dependent diabetics (mean secretion index 134 +/- 17 versus 145 +/- 23 (SEM) % in four control subjects). Lymphocytes inhibiting islet cell response were not cytotoxic against mouse fibroblasts. Twenty-two insulin-dependent diabetics showed islet cell antibodies to human and/or mouse pancreatic islets. However, an inhibition of insulin release was found with no detectable islet cell antibodies in one case, and the converse in two cases. Lymphocyte cytotoxicity to islet cells could play a role in the natural history of insulin-dependent diabetes.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Child, Preschool
  • Cytotoxicity, Immunologic
  • Diabetes Mellitus / immunology*
  • Diabetes Mellitus, Type 1 / immunology*
  • Female
  • Fibroblasts / immunology
  • Humans
  • Insulin / metabolism*
  • Insulin Antibodies
  • Insulin Secretion
  • Islets of Langerhans / metabolism*
  • Lymphocytes / immunology*
  • Male
  • Mice
  • Mice, Inbred DBA
  • Middle Aged
  • Organ Specificity


  • Insulin
  • Insulin Antibodies